We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Our knowledge, expertise & publications
Deals & Cases
30 May 2022
VISCHER has advised ADVANZ PHARMA, a specialty pharmaceutical company headquartered in London, on all Swiss legal aspects of its USD 450m acquisition of the ex-US business of Intercept Pharmaceuticals, spanning from due diligence to transactional document advice. White & Case acted as lead counsel in this transaction. The acquisition is expected to be completed during the third quarter 2022, subject to customary legal and regulatory closing conditions.
The transaction is actively supported by ADVANZ PHARMA's owner Nordic Capital, a leading private equity investor with extensive experience and expertise in the global healthcare market, which acquired ADVANZ PHARMA in June 2021.
The VISCHER team led by partner Dr. Adrian Dörig (Corporate Finance) comprised Dr. Peter Kühn (Counsel, Corporate/M&A), Anna Salm (Junior Associate, Corporate/M&A) and Gian Geel (Associate, Employment).
Categories: Mergers & Acquisitions, Deals & Cases
Attorney at Law
On 28 July 2022, Ningbo Shanshan Co. raised USD 310.5m through GDRs issuance and listing on the SIX...
We are particularly proud of our Tier 1 ranking in the "Financial services regulatory" area. In the...
About three months ago the London-Shanghai Stock Connect program was expanded to now include...
Opt-in for our regular updates, news, views, insights and more.